n.yildiz
Submits third-party assay reports on material purchased directly. Based in Nantes.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.35%
n=9
Suppliers covered
9
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041950 | Oxytocin | AMB | AMB-2602-G4870 | Janoshik | 2026-Q2 | 99.82 | 3.21 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018566 | Tirzepatide | QYB | QYB-2507-T4628 | Janoshik | 2025-Q4 | 99.11 | 6.51 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019509 | 5-Amino-1MQ | JEEP | JEEP-2412-M9286 | PeptideMeter | 2025-Q2 | 99.35 | 5.87 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-018771 | MK-677 (Ibutamoren mesylate) | FGP | FGP-2502-F7880 | Janoshik | 2025-Q2 | 99.45 | 4.21 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-020967 | Tirzepatide | WXT | WXT-2411-F3188 | Janoshik | 2025-Q2 | 98.54 | 4.78 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019830 | KPV | Homopeptide | HOMO-2411-P5026 | PeptideMeter | 2025-Q1 | 98.93 | 4.83 | 93.5 | Buyer-sourced | 1 | FAIL |
| AX-2025-019378 | GHRP-2 | HYB | HYB-2501-R7240 | Kestrel | 2025-Q1 | 99.80 | 4.48 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005130 | Tirzepatide | SGN | SGN-2408-S8580 | Janoshik | 2024-Q4 | 97.86 | 3.69 | 90.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004963 | PT-141 (Bremelanotide) | MKM | MKM-2404-E3617 | Janoshik | 2024-Q3 | 99.93 | 4.73 | — | Laboratory-retained | 0 | PASS |